Literature DB >> 22490438

Constitutive nuclear localization of NFAT in Foxp3+ regulatory T cells independent of calcineurin activity.

Qiuxia Li1, Arvind Shakya, Xiaohua Guo, Hongbo Zhang, Dean Tantin, Peter E Jensen, Xinjian Chen.   

Abstract

Foxp3 plays an essential role in conferring suppressive functionality to CD4(+)/Foxp3(+) regulatory T cells (Tregs). Although studies showed that Foxp3 has to form cooperative complexes with NFAT to bind to target genes, it remains unclear whether NFAT is available in the nucleus of primary Tregs for Foxp3 access. It is generally believed that NFAT in resting cells resides in the cytoplasm, and its nuclear translocation depends on calcineurin (CN) activation. We report that a fraction of NFAT protein constitutively localizes in the nucleus of primary Tregs, where it selectively binds to Foxp3 target genes. Treating Tregs with CN inhibitor does not induce export of NFAT from the nucleus, indicating that its nuclear translocation is independent of CN activity. Consistently, Tregs are resistant to CN inhibitors in the presence of IL-2 and continue to proliferate in response to anti-CD3 stimulation, whereas proliferation of non-Tregs is abrogated by CN inhibitors. In addition, PMA, which activates other transcription factors required for T cell activation but not NFAT, selectively induces Treg proliferation in the absence of ionomycin. TCR interaction with self-MHC class II is not required for PMA-induced Treg proliferation. Tregs expanded by PMA or in the presence of CN inhibitors maintain Treg phenotype and functionality. These findings shed light on Treg biology, paving the way for strategies to selectively activate Tregs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22490438     DOI: 10.4049/jimmunol.1102376

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors.

Authors:  Gavin Whitehouse; Elizabeth Gray; Sotiris Mastoridis; Elliot Merritt; Elisavet Kodela; Jennie H M Yang; Richard Danger; Marta Mairal; Sofia Christakoudi; Juan J Lozano; Iain C Macdougall; Timothy I M Tree; Alberto Sanchez-Fueyo; Marc Martinez-Llordella
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-05       Impact factor: 11.205

2.  Efficient chromatin immunoprecipitation using limiting amounts of biomass.

Authors:  Dean Tantin; Warren P Voth; Arvind Shakya
Journal:  J Vis Exp       Date:  2013-05-01       Impact factor: 1.355

Review 3.  NFAT as cancer target: mission possible?

Authors:  Jiang-Jiang Qin; Subhasree Nag; Wei Wang; Jianwei Zhou; Wei-Dong Zhang; Hui Wang; Ruiwen Zhang
Journal:  Biochim Biophys Acta       Date:  2014-07-26

4.  Dependence on nuclear factor of activated T-cells (NFAT) levels discriminates conventional T cells from Foxp3+ regulatory T cells.

Authors:  Martin Vaeth; Ulrike Schliesser; Gerd Müller; Sonja Reissig; Kazuki Satoh; Andrea Tuettenberg; Helmut Jonuleit; Ari Waisman; Martin R Müller; Edgar Serfling; Birgit S Sawitzki; Friederike Berberich-Siebelt
Journal:  Proc Natl Acad Sci U S A       Date:  2012-09-18       Impact factor: 11.205

5.  Tumor Tolerance-Promoting Function of Regulatory T Cells Is Optimized by CD28, but Strictly Dependent on Calcineurin.

Authors:  Francesco Marangoni; Ruan Zhang; Vinidhra Mani; Martin Thelen; Noor J Ali Akbar; Ross D Warner; Tarmo Äijö; Valentina Zappulli; Gustavo J Martinez; Laurence A Turka; Thorsten R Mempel
Journal:  J Immunol       Date:  2018-04-16       Impact factor: 5.422

6.  BRG1-mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling.

Authors:  Barbara H Chaiyachati; Anant Jani; Yisong Wan; Haichang Huang; Richard Flavell; Tian Chi
Journal:  EMBO J       Date:  2013-01-15       Impact factor: 11.598

Review 7.  Impact of Immune-Modulatory Drugs on Regulatory T Cell.

Authors:  Akiko Furukawa; Steven A Wisel; Qizhi Tang
Journal:  Transplantation       Date:  2016-11       Impact factor: 4.939

Review 8.  Context and location dependence of adaptive Foxp3(+) regulatory T cell formation during immunopathological conditions.

Authors:  Joshua F Heiber; Terrence L Geiger
Journal:  Cell Immunol       Date:  2012-10-01       Impact factor: 4.868

9.  Transcription factor FOXP2 is a flow-induced regulator of collecting lymphatic vessels.

Authors:  Magda N Hernández Vásquez; Maria H Ulvmar; Alejandra González-Loyola; Ioannis Kritikos; Ying Sun; Liqun He; Cornelia Halin; Tatiana V Petrova; Taija Mäkinen
Journal:  EMBO J       Date:  2021-05-02       Impact factor: 11.598

10.  Epigenetic control of Foxp3 by SMYD3 H3K4 histone methyltransferase controls iTreg development and regulates pathogenic T-cell responses during pulmonary viral infection.

Authors:  D E de Almeida Nagata; H-A Ting; K A Cavassani; M A Schaller; S Mukherjee; C Ptaschinski; S L Kunkel; N W Lukacs
Journal:  Mucosal Immunol       Date:  2015-02-11       Impact factor: 7.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.